| 期 |
标题 |
文件 |
| 卷 30, 编号 39 (2024) |
Mechanism of Action of NvZhen ErXian HeJi in Ovariectomized Rats with Myocardial Infarction based on Network Pharmacology |
(Eng)
|
|
Wu K., Guo S., Zhang J., Wen D., Zhang L., Zhu M., Wang X., Li X., Chen Z., Lin F.
|
| 卷 30, 编号 39 (2024) |
Effects of CYP3A5 Genetic Polymorphisms on the Weight-adjusted through Concentration of Sirolimus in Renal Transplant Recipients: A Systematic Review and Meta-analysis |
(Eng)
|
|
Park Y., Park J., Yee J., Gwak H.
|
| 卷 30, 编号 39 (2024) |
Magnesium (Mg2+): Essential Mineral for Neuronal Health: From Cellular Biochemistry to Cognitive Health and Behavior Regulation |
(Eng)
|
|
Kumar A., Mehan S., Tiwari A., Khan Z., Gupta G., Narula A., Samant R.
|
| 卷 30, 编号 39 (2024) |
Anti-cancer Drug Targeting using Stimuli Sensitive Mesoporous Silica Nanoparticle in Colorectal Cancer |
(Eng)
|
|
Mainuddin ., Kumar A., Sharma A., Sharma N.
|
| 卷 30, 编号 38 (2024) |
Mechanisms Underlying the Therapeutic Effects of Nicotinamide Mononucleotide in Treating High-fat Diet-induced Hypertrophic Cardiomyopathy based on GEO Datasets, Network Pharmacology, and Molecular Docking |
(Eng)
|
|
Han Y., Wang L., Zhang Y., Zhou A., Wang Z., Dong W., Wang J., Wang T., Zou J.
|
| 卷 30, 编号 38 (2024) |
Exploring the Biomarkers and Potential Mechanisms of Botulinum Toxin Type A in the Treatment of Microglial Inflammatory Activation through P2X7 Receptors based on Transcriptome Sequencing |
(Eng)
|
|
Zhang K., Ren Y., Lv J., Mao P., Zhou W., Shi Y., Zhou K., Wang L., Zhang C., Zhang H.
|
| 卷 30, 编号 38 (2024) |
Nanomaterials in Targeting Cancer Cells with Nanotherapeutics: Transitioning Towards Responsive Systems |
(Eng)
|
|
Jain B., Verma D., Rawat R., Berdimurodov E.
|
| 卷 30, 编号 38 (2024) |
A New Frontier in Phytotherapy: Harnessing the Therapeutic Power of Medicinal Herb-derived miRNAs |
(Eng)
|
|
Feng Y.
|
| 卷 30, 编号 38 (2024) |
3D Printed Nanosensors for Cancer Diagnosis: Advances and Future Perspective |
(Eng)
|
|
Gupta B., Malviya R., Srivastava S., Ahmad I., Rab S., Singh D.
|
| 卷 30, 编号 37 (2024) |
Evaluation of the Hypoglycemic and Hypolipidemic Potential of Extract Fraction of Quercus baloot Griff Seeds in Alloxan-induced Diabetic Mice |
(Eng)
|
|
Musa M., Rahman S., Ali N., Hamayun M., Alrefai A., Almutairi M., Azmat R., Ali S., Hussain S., Gul Jan F., Jan G., Irfan M.
|
| 卷 30, 编号 37 (2024) |
Exploration of Pharmacological Mechanism of Cinnamomum tamala Essential Oil in Treating Inflammation based on Network Pharmacology, Molecular Modelling, and Experimental Validation |
(Eng)
|
|
Mohanty D., Padhee S., Jena S., Sahoo A., Panda P., Nayak S., Ray A.
|
| 卷 30, 编号 40 (2024) |
Immune-mediated Bowel Disease: Role of Intestinal Parasites and Gut Microbiome |
(Eng)
|
|
Chowdhury S., Dey A., Gautam M., Mondal S., Pawar S., Ranade A., Bora M., Gangwar M., Teli A., Mondal N.
|
| 卷 30, 编号 40 (2024) |
Sesamol Loaded Silver Nanoparticles Gel Engineered for Wound Healing via Topical Delivery: Optimization In vitro and Ex vivo Evaluation |
(Eng)
|
|
Makeen H., Albratty M.
|
| 卷 30, 编号 42 (2024) |
Transformative Potential and Healthcare Applications of 3D Printing |
(Eng)
|
|
Prakash A., Malviya R., Singh D.
|
| 卷 30, 编号 41 (2024) |
Cpd861 Targeting BCL2 to Alleviate Hepatic Fibrosis: Network Pharmacology, Mendelian Randomization, and Molecular Docking Mechanisms |
(Eng)
|
|
Lyu Y., Liang X., Gao S., Li J., Li J., Zhang S., Yin C., Chi C.
|
| 卷 30, 编号 41 (2024) |
Revolutionizing Antiviral Therapeutics: In silico Approaches for Emerging and Neglected RNA Viruses |
(Eng)
|
|
Sharma K., Singh M., Sharma S.
|
| 卷 30, 编号 41 (2024) |
Murraya koenigii (L.) Spreng. as a Natural Intervention for Diabesity: A Review |
(Eng)
|
|
Jachak S., Thakur M., Ahirrao P., Goyal A.
|
| 卷 30, 编号 41 (2024) |
Biocompatible Electrospun Hydrogel Fibers for Advanced Wound Healing Therapies |
(Eng)
|
|
Yadav P., Gupta M., Singh S., Parashar P.
|
| 卷 30, 编号 41 (2024) |
Some Highly Potent Nepalese Medicinal Plants with Antimicrobial Properties |
(Eng)
|
|
Khanal A., Shrestha S., Adhikari R.
|
| 卷 30, 编号 4 (2024) |
Unveiling the Potential of Serum MiR-483-5p: A Promising Diagnostic and Prognostic Biomarker in OLP and OSCC Patients by In silico Analysis of Differential Gene Expression |
(Eng)
|
|
Soltaninezhad P., Arab F., Mohtasham N., FakherBaheri M., Kavishahi N., Aghaee-Bakhtiari S., Zare-Mahmoodabadi R., Pakfetrat A., Taban K., Mohajertehran F.
|
| 卷 30, 编号 4 (2024) |
Deciphering Multi-target Pharmacological Mechanism of Cucurbita pepo Seeds against Kidney Stones: Network Pharmacology and Molecular Docking Approach |
(Eng)
|
|
Shahzadi A., Ashfaq U., Khurshid M., Nisar M., Syed A., Bahkali A.
|
| 卷 30, 编号 4 (2024) |
Network Pharmacology and In vitro Experimental Verification to Explore the Mechanism of Chaiqin Qingning Capsule in the Treatment of Pain |
(Eng)
|
|
Gao H., Chen Z., Halihaman B., Huang L., Wang Z., Ding X.
|
| 卷 30, 编号 4 (2024) |
Applications of Pyrrole and Pyridine-based Heterocycles in Cancer Diagnosis and Treatment |
(Eng)
|
|
Tyagi R., Yadav K., Srivastava N., Sagar R.
|
| 卷 30, 编号 4 (2024) |
Human Data on Pharmacokinetic Interactions of Cannabinoids: A Narrative Review |
(Eng)
|
|
Maldonado C., Peyraube R., Fagiolino P., Oricchio F., Cuñetti L., Vázquez M.
|
| 卷 30, 编号 40 (2024) |
Preparation and Characterization of Nanostructured Lipid Carriers (NLCs) Containing Glycyrrhiza glabra Extract for the Treatment of Skin Hyperpigmentation |
(Eng)
|
|
Hoseinsalari A., Atapour-Mashhad H., Asili J., Tayarani-Najaran Z., Mohtashami L., Khanavi M., Vazirian M., Akbari Javar H., Niknam S., Golmohammadzadeh S., Ardekani M.
|
| 卷 30, 编号 40 (2024) |
Correlation between the Atherogenic Index of Plasma and Progression of Non-target Lesion Vascular Disease Following Percutaneous Coronary Intervention using Drug-eluting Stents |
(Eng)
|
|
Hou T., Wang F., Hao C., Zhang C., Ning M., Chen Y., Wang K., Liu Y.
|
| 卷 30, 编号 40 (2024) |
Experiments Validated the Development of Zebrafish Embryos and Toxicological Mechanism of Borneols in Perinatal Period |
(Eng)
|
|
Xie Q., Lu D., Ma R., Zeng X., Guo J.
|
| 卷 30, 编号 37 (2024) |
Methodological Approaches for Increasing the Retroviral Transduction Efficiency of Primary NK Cells |
(Eng)
|
|
Streltsova M., Palamarchuk A., Vavilova J., Ustiuzhanina M., Boyko A., Velichinskii R., Alekseeva N., Grechikhina M., Shustova O., Sapozhnikov A., Kovalenko E.
|
| 卷 30, 编号 27 (2024) |
Design, Synthesis and Evaluation of a Novel Teoptinib Derivative as an Effective Anti-hepatocellular Carcinoma Agent |
(Eng)
|
|
Yu H., Zhang X., Li J., Wang K., Yin C., Li X., Li L., Shao G., Jin S.
|
| 卷 30, 编号 18 (2024) |
Synthesis of Rupestonic Acid L-Ephedrine Derivatives with Preliminary In vitro Anti-influenza Viral Activity |
(Eng)
|
|
Yong J., Lu C.
|
| 卷 30, 编号 15 (2024) |
Corrigendum: N-unsubstituted Imidazoles: Design, Synthesis, and Antimicrobial Evaluation |
(Eng)
|
|
Davood A., EbrahimiNassimi Y., Sardari S., Farahani Y.
|
| 卷 30, 编号 15 (2024) |
Studies in Solid Solution Formation between Acetaminophen and Povidone and Mouth-dissolving Strip Formulation |
(Eng)
|
|
Shahiwala A.
|
| 卷 30, 编号 15 (2024) |
Association of Parity with the Risks of Gestational Diabetes and Macrosomia: A Retrospective Cohort Study in Nanjing, China |
(Eng)
|
|
Geng S., Wang J., Geng Z., Wen J.
|
| 卷 30, 编号 15 (2024) |
Molecular Mechanisms of Medicinal Plant Securinega suffruticosa-derived Compound Securinine against Spinal Muscular Atrophy based on Network Pharmacology and Experimental Verification |
(Eng)
|
|
Zhang Y., He J., Xiang L., Tang X., Wang S., Li A., Wang C., Li L., Zhu B.
|
| 卷 30, 编号 15 (2024) |
Effectiveness and Safety of Different Oral Anticoagulants with P-glycoprotein/ CYP3A4 Inhibitors: A Network Meta-analysis |
(Eng)
|
|
Yang S., Xu Y., Zhang Y., Li D., Li X.
|
| 卷 30, 编号 15 (2024) |
CASC19: An Oncogenic Long Non-coding RNA in Different Cancers |
(Eng)
|
|
Wu Y., Mou J., Zhou G., Yuan C.
|
| 卷 30, 编号 15 (2024) |
Why have SGLT2 Inhibitors Failed to Achieve the Desired Success in COVID-19? |
(Eng)
|
|
Cumhur Cure M., Cure E.
|
| 卷 30, 编号 15 (2024) |
Design of Nanodrug Delivery Systems for Tumor Bone Metastasis |
(Eng)
|
|
Zhai X., Peng S., Zhai C., Wang S., Xie M., Guo S., Bai J.
|
| 卷 30, 编号 15 (2024) |
CRISPR and Gene Editing: A Game-changer in Drug Development |
(Eng)
|
|
Verma A., Sharma T., Awasthi A.
|
| 卷 30, 编号 15 (2024) |
Survival of Patients with Primary Brain Tumor: A Data Analysis of 10 Years |
(Eng)
|
|
Verma S., Malviya R., Uniyal P.
|
| 卷 30, 编号 14 (2024) |
Zamzam Water Mitigates Cardiac Toxicity Risk through Modulation of GUT Microbiota and the Renin-angiotensin System |
(Eng)
|
|
Anwar F., Sheikh R., Nadem M., Asar T., Almujtaba M., Naqvi S., Al-Abbasi F., Almalki N., Kumar V.
|
| 卷 30, 编号 14 (2024) |
Identification of Drug Targets and Agents Associated with Ferroptosis-related Osteoporosis through Integrated Network Pharmacology and Molecular Docking Technology |
(Eng)
|
|
Huo K., Yang Y., Yang T., Zhang W., Shao J.
|
| 卷 30, 编号 14 (2024) |
Exploration of the Mechanisms Underlying Yu's Enema Formula in Treating Ulcerative Colitis by Blocking the RhoA/ROCK Pathway based on Network Pharmacology, High-performance Liquid Chromatography Analysis, and Experimental Verification |
(Eng)
|
|
Liu B., Zhang J., Wang X., Ye W., Yao J.
|
| 卷 30, 编号 14 (2024) |
Enhancing the Antiproliferative Activity of Perillyl Alcohol against Glioblastoma Cell Lines through Synergistic Formulation with Natural Oils |
(Eng)
|
|
Alharbi W., Alshehri A., Ahmed T., Md. S., Almehmady A., Alshabibi M., Altamimi R., El-Say K.
|
| 卷 30, 编号 16 (2024) |
A Comprehensive Guide to the Development, Evaluation, and Future Prospects of Self-nanoemulsifying Drug Delivery Systems for Poorly Water-soluble Drugs |
(Eng)
|
|
Chauhan A., Kamal R., Mishra R., Shekho D., Awasthi A.
|
| 卷 30, 编号 16 (2024) |
Recent Advancements in Refashioning of NSAIDs and their Derivatives as Anticancer Candidates |
(Eng)
|
|
Kassab A., Gedawy E.
|
| 卷 30, 编号 18 (2024) |
Colorectal Cancer Stem Cell Biomarkers: Biological Traits and Prognostic Insights |
(Eng)
|
|
Soleimani A., Saeedi N., Al-Asady A., Nazari E., Hanaie R., Khazaei M., Ghorbani E., Akbarzade H., Ryzhikov M., Avan A., Mehr S.
|
| 卷 30, 编号 18 (2024) |
Treatment of Pulmonary Embolism beyond Anticoagulation |
(Eng)
|
|
Lakkas L., Katsouras C.
|
| 卷 30, 编号 18 (2024) |
Evaluating the Imperative Role of Pre- and Post-eCTD Standards in Dossier Validation: An Inevitable Outlook |
(Eng)
|
|
Patil N., Ranjan A., Narang R., Singh A.
|
| 卷 30, 编号 17 (2024) |
Corrigendum to: Mechanism of HSP90 Inhibitor in the Treatment of DSS-induced Colitis in Mice by Inhibiting MAPK Pathway and Synergistic Effect of Compound Sophorae Decoction |
(Eng)
|
|
Yuan Y., Wu H., Shuai B., Liu C., Zhu F., Gao F., Wei C., Fan H.
|
| 卷 30, 编号 17 (2024) |
Network Pharmacology Study on Herb Pair Bletilla striata-Galla chinensis in the Treatment of Chronic Skin Ulcers |
(Eng)
|
|
Wang Y., Ding T., Jiang X.
|
| 卷 30, 编号 17 (2024) |
Impact of Combination Therapy with Chemical Drugs and Megavoltage X-ray Exposure on Breast Cancer Stem Cells Viability and Proliferation of MCF-7 and MDA-MB-231 Cell Lines |
(Eng)
|
|
Banisharif Dehkordi F., Ghatrehsamani M., Abdolvand M., Soltani A., Masoumi S.
|
| 卷 30, 编号 17 (2024) |
Network Pharmacology, Molecular Docking Analysis and Molecular Dynamics Simulation of Scutellaria baicalensis in the Treatment of Liver Fibrosis |
(Eng)
|
|
Wang J., Wu Z., Chen X., Sun Y., Ma S., Weng J., Zhang Y., Dong K., Shao J., Zheng S.
|
| 卷 30, 编号 17 (2024) |
Neuropilin-1 Binding Peptide as Fusion to Diphtheria Toxin Induces Apoptosis in Non-small Cell Lung Cancer Cell Line |
(Eng)
|
|
Eghtedari S., Behdani M., Kazemi-Lomedasht F.
|
| 卷 30, 编号 17 (2024) |
Lipase and Protease Production Ability of Multi-drug Resistant Bacteria Worsens the Outcomes of Wound Infections |
(Eng)
|
|
Rahman A., Sardar S., Niaz Z., Khan A., Sheheryar S., Alrefaei A., Hamayun M., Ali S.
|
| 卷 30, 编号 17 (2024) |
The Therapeutic Application of Hydrogen in Cancer: The Potential and Challenges |
(Eng)
|
|
Khiji M., Arghidash F., Tanha G., Zadeh R., Ghorbani E., Khazaei M., Hassanian S., Gataa I., Lam A., Giovannetti E., Ferns G., Nazari E., Avan A.
|
| 卷 30, 编号 16 (2024) |
Mechanism Research of PZD Inhibiting Lung Cancer Cell Proliferation, Invasion, and Migration based on Network Pharmacology |
(Eng)
|
|
Feng F., Hu P., Peng L., Chen J., Tao X.
|
| 卷 30, 编号 16 (2024) |
Celastrol Elicits Antitumor Effects through Inducing Immunogenic Cell Death and Downregulating PD-L1 in ccRCC |
(Eng)
|
|
Li H., Zhu N., Wu J., Shi Y., Gu J., Qin L.
|
| 卷 30, 编号 16 (2024) |
Elucidation of the Molecular Mechanism of Compound Danshen Dripping Pills against Angina Pectoris based on Network Pharmacology and Molecular Docking |
(Eng)
|
|
Tian X., Yin S., Liu Z., Cao J., Liu X., Qiu Q.
|
| 卷 30, 编号 16 (2024) |
Preclinical Pharmacokinetics and Pharmacology Study of RC98: A Programmed Cell Death Ligand 1 Monoclonal Antibody in Cynomolgus Monkeys |
(Eng)
|
|
Li S., Dong L., Jiang J., Wang L., Li Q., Deng C., Liu Z., Wang F.
|
| 卷 30, 编号 14 (2024) |
The Role of Traditional Chinese Medicine and Chinese Pharmacopoeia in the Evaluation and Treatment of COVID-19 |
(Eng)
|
|
Gasmi A., Noor S., Dadar M., Semenova Y., Menzel A., Gasmi Benahmed A., Bjørklund G.
|
| 卷 30, 编号 14 (2024) |
Innovative Strategies to Enhance mRNA Vaccine Delivery and Effectiveness: Mechanisms and Future Outlook |
(Eng)
|
|
Verma A., Awasthi A.
|
| 卷 30, 编号 11 (2024) |
Machine-learning-guided Directed Evolution for AAV Capsid Engineering |
(Eng)
|
|
Fu X., Suo H., Zhang J., Chen D.
|
| 卷 30, 编号 11 (2024) |
Revolutionizing Drug Discovery: The Role of Artificial Intelligence and Machine Learning |
(Eng)
|
|
Verma A., Awasthi A.
|
| 卷 30, 编号 1 (2024) |
Marein Ameliorates Myocardial Fibrosis by Inhibiting HIF-1α and TGF-β1/Smad2/3 Signaling Pathway in Isoproterenol-stimulated Mice and TGF-β1-stimulated Cardiac Fibroblasts |
(Eng)
|
|
Niu G., Zhao Y., Song H., Song Q., Yin X., Zhu Z., Xu J.
|
| 卷 30, 编号 1 (2024) |
Breast Cancer-related Lymphedema: Recent Updates on Clinical Efficacy of Therapies and Bioengineering Approaches for a Personalized Therapy |
(Eng)
|
|
Zhang X., Beeraka N., Sinelnikov M., Glazachev O., Ternovoy K., Lu P., Isaeva A., Cao Y., Zhang J., Nezhad A., Plotnikova M., Chen K.
|
| 卷 30, 编号 1 (2024) |
Nanocomposite Hydrogels-A Promising Approach towards Enhanced Bioavailability and Controlled Drug Delivery |
(Eng)
|
|
Shahid N., Erum A., Hanif S., Malik N., Tulain U., Syed M.
|
| 卷 30, 编号 1 (2024) |
Differential Signaling Pathways in Medulloblastoma: Nano-biomedicine Targeting Non-coding Epigenetics to Improve Current and Future Therapeutics |
(Eng)
|
|
Sokolov D., Sharda N., Banerjee A., Denisenko K., Basalious E., Shukla H., Waddell J., Hamdy N., Banerjee A.
|
| 卷 30, 编号 1 (2024) |
A Mechanistic Review on Therapeutic Potential of Medicinal Plants and their Pharmacologically Active Molecules for Targeting Metabolic Syndrome |
(Eng)
|
|
Gauttam V., Munjal K., Chopra H., Ahmad A., Rana M., Kamal M.
|
| 卷 30, 编号 1 (2024) |
Role of Amphotericin B in the Treatment of Mucormycosis |
(Eng)
|
|
Sachdeva A., Targhotra M., Kanwar Chauhan M., Chopra M.
|
| 卷 30, 编号 1 (2024) |
Foreword |
(Eng)
|
|
Antonelli A.
|
| 卷 30, 编号 10 (2024) |
Challenging Axillary Lymph Nodes on PET/CT in Cancer Patients throughout COVID-19 Vaccination Era |
(Eng)
|
|
Giordano A., Gallicchio R., Milella M., Storto R., Nardelli A., Pellegrino T., Nappi A., Di Cosola M., Storto G.
|
| 卷 30, 编号 10 (2024) |
Preparation Optimization and Immunological Activity Studies of Portulaca oleracea L. Polysaccharides Liposomes |
(Eng)
|
|
Li Y., Jia G., Li T., Zhou X., Zhao H., Cao J., Guan Z., Zhao R.
|
| 卷 30, 编号 10 (2024) |
Cumulative Exposure to Oxidized Low-density Lipoprotein is a Potential Predictor for Prognosis in Acute Ischemic Stroke: A Cohort Study |
(Eng)
|
|
Cheng K., Chen X., Luo Y., Sun W., Yang X., Huang S., Wang Y., Wu D.
|
| 卷 30, 编号 10 (2024) |
Current and Emerging Pharmacological Therapies for Cushing's Disease |
(Eng)
|
|
Divaris E., Kostopoulos G., Efstathiadou Z.
|
| 卷 30, 编号 10 (2024) |
Cholesteryl Ester Transfer Protein (CETP) Variations in Relation to Lipid Profiles and Cardiovascular Diseases: An Update |
(Eng)
|
|
Dabravolski S., Orekhov N., Melnichenko A., Sukhorukov V., Popov M., Orekhov A.
|
| 卷 30, 编号 11 (2024) |
Advances in the Treatment of Kidney Disorders using Mesenchymal Stem Cells |
(Eng)
|
|
Rajput S., Malviya R., Uniyal P.
|
| 卷 30, 编号 11 (2024) |
A Snapshot of Selenium-enclosed Nanoparticles for the Management of Cancer |
(Eng)
|
|
Deshmukh R., Singh R., Sharma S., Mishra A., Harwansh R.
|
| 卷 30, 编号 13 (2024) |
Vaccinomics: Paving the Way for Personalized Immunization |
(Eng)
|
|
Al-Eitan L., ElMotasem M., Khair I., Alahmad S.
|
| 卷 30, 编号 13 (2024) |
Investigating Bacopa monnieri L. Therapeutic Potential for the Treatment of Neurological Diseases |
(Eng)
|
|
Srivastava P., Yadav D., Singh S., Kim S., Singh S., Katiyar S., Song M.
|
| 卷 30, 编号 13 (2024) |
Medicinal Plant-derived Phytochemicals in Detoxification |
(Eng)
|
|
Bjørklund G., Cruz-Martins N., Goh B., Mykhailenko O., Lysiuk R., Shanaida M., Lenchyk L., Upyr T., Rusu M., Pryshlyak A., Shanaida V., Chirumbolo S.
|
| 卷 30, 编号 13 (2024) |
The Application of Nanotechnological Therapeutic Platforms against Gynecological Cancers |
(Eng)
|
|
Keyvani V., Mollazadeh S., Riahi E., Mahmoudian R., Tabari M., Lagzian E., Ghorbani E., Akbarzade H., Gholami A., Gataa I., Hassanian S., Ferns G., Khazaei M., Avan A., Anvari K.
|
| 卷 30, 编号 13 (2024) |
Cellular and Mitochondrial Pathways Contribute to SGLT2 Inhibitors-mediated Tissue Protection: Experimental and Clinical Data |
(Eng)
|
|
Sanz R., Menéndez S., Inserra F., Ferder L., Manucha W.
|
| 卷 30, 编号 12 (2024) |
Network Pharmacology along with Molecular Docking to Explore the Mechanism of Danshen Injection against Anthracycline-induced Cardiotoxicity and Transcriptome Validation |
(Eng)
|
|
Dai Q., Pan Y., Zhu X., Chen M., Xie L., Zhu Y., Wan G.
|
| 卷 30, 编号 12 (2024) |
Development and Validation of a Prognostic Model based on 11 E3-related Genes for Colon Cancer Patients |
(Eng)
|
|
JIang W., Dong J., Zhang W., Huang Z., Guo T., Zhang K., Jiang X., Du T.
|
| 卷 30, 编号 12 (2024) |
Deformable Vesicles with Edge Activators for the Transdermal Delivery of Non-Psychoactive Cannabinoids |
(Eng)
|
|
Vettorato E., Fiordelisi M., Ferro S., Zanin D., Franceschinis E., Marzaro G., Realdon N.
|
| 卷 30, 编号 12 (2024) |
Compounds based on Adamantyl-substituted Amino Acids and Peptides as Potential Antiviral Drugs Acting as Viroporin Inhibitors |
(Eng)
|
|
Garaev T., Grebennikova T., Lebedeva V., Avdeeva V., Larichev V.
|
| 卷 30, 编号 12 (2024) |
Revisiting the Mitochondrial Function and Communication in Neurodegenerative Diseases |
(Eng)
|
|
Wankhede N., Kale M., Umare M., Lokhande S., Upaganlawar A., Wal P., Taksande B., Umekar M., Khandige P., Singh B., Sadananda V., Ramniwas S., Behl T.
|
| 卷 30, 编号 12 (2024) |
A Review on Novel Therapeutic Modalities and Evidence-based Drug Treatments against Allergic Rhinitis |
(Eng)
|
|
Kumar B., Deshmukh R.
|
| 卷 30, 编号 11 (2024) |
Remedial Dosing Recommendations for Sirolimus Delayed or Missed Dosages Caused by Poor Medication Compliance in Pediatric Tuberous Sclerosis Complex Patients |
(Eng)
|
|
Yang Y., Jiang L., Zhu H., Sun W., Mao J., Miao J., Wang Y., He S., Wang D., Chen X.
|
| 卷 30, 编号 11 (2024) |
Specific Targeting of Zinc Transporter LIV-1 with Immunocytokine Containing Anti-LIV-1 VHH and Human IL-2 and Evaluation of its In vitro Antitumor Activity |
(Eng)
|
|
Dehghan R., Parikhani A., Cohan R., Shokrgozar M., Mirabzadeh E., Ajdary S., Zeinali S., Ghaderi H., Talebkhan Y., Behdani M.
|
| 卷 30, 编号 11 (2024) |
Repurposing of Angiotensin-converting-enzyme Inhibitor on Prevention of Post-surgical Tendon Adhesion |
(Eng)
|
|
Naimi H., Khazaei M., Sharifnia F., Sayyed-Hosseinian S.
|
| 卷 30, 编号 10 (2024) |
The Emerging Role of Cell Membrane-coated Nanomaterials in Cancer Therapy |
(Eng)
|
|
Bhattacharya S., Beninger P.
|
| 卷 30, 编号 27 (2024) |
Effect of Ozone Therapy on Diabetes-related Foot Ulcer Outcomes: A Systematic Review and Meta-analysis |
(Eng)
|
|
Izadi M., Jafari-Oori M., Eftekhari Z., Jafari N., Maybodi M., Heydari S., Vahedian-Azimi A., Atkin S., Jamialahmadi T., Sahebkar A.
|
| 卷 30, 编号 24 (2024) |
Qingxiong Ointment and its Active Ingredient, Shikonin Treat Psoriasis through HIF-1 Signaling Pathway |
(Eng)
|
|
Zhang B., Yan G., Li F., Tang Y., Xu G., Zhang Y., Ze K.
|
| 卷 30, 编号 24 (2024) |
Protective Effect and Related Mechanism of Modified Danggui Buxue Decoction on Retinal Oxidative Damage in Mice based on Network Pharmacology |
(Eng)
|
|
Hu X., Liu F., Yang H., Qi M., Ren Y., Zhu W., Dai C.
|
| 卷 30, 编号 24 (2024) |
Exploring the Molecular Mechanisms of Huaier on Modulating Metabolic Reprogramming of Hepatocellular Carcinoma: A Study based on Network Pharmacology, Molecular Docking and Bioinformatics |
(Eng)
|
|
Wan Y., Jiang H., Liu Z., Bai C., Lian Y., Zhang C., Zhang Q., Huang J.
|
| 卷 30, 编号 24 (2024) |
Impact of Bioactive Compounds in the Management of Various Inflammatory Diseases |
(Eng)
|
|
Babbar R., Kaur A., Vanya ., Arora R., Gupta J., Wal P., Tripathi A., Koparde A., Goyal P., Ramniwas S., Gulati M., Behl T.
|
| 卷 30, 编号 24 (2024) |
Pharmacological Mechanism of Herbal Interventions for Bipolar Disorder |
(Eng)
|
|
Singh A., Sarwat M., Gupta S.
|
| 卷 30, 编号 23 (2024) |
Synthesis, Characterization, and Antimicrobial Evaluation of Schiff Base-mixed Ligand Complexes with Divalent Metal Ions Derived from Amoxicillin and Vanillin/Nicotinamide |
(Eng)
|
|
Bahry M., Al-Noor T., Fardous A., Heydari A., Abdou A., Fayez S., El-Shazly M., Saleh N.
|
| 101 - 200 的 257 信息 |
<< < 1 2 3 > >>
|
